Collaboration with SRI Provides Q BioMed Expertise in Formulation Development and Preclinical Work in...November-28-2018
Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22...October-26-2018
Q BioMed Orphan Drug VP, who started the first Expanded Access Program Database asked to Speak on...
RECENT SEC FILINGS
Description Form Date 8-K Current report 2019-01-07 EFFECT Notice of Effectiveness 2018-12-26 S-1/A General form for registration of securities under the Securities Act of 1933 2018-12-13 CT ORDER Confidential treatment order 2018-12-06 8-K Current report 2018-11-28 8-K Current report 2018-11-02 S-1 General form for registration of securities under the Securities Act of 1933 2018-10-25 10-Q/A Quarterly report [Sections 13 or 15(d)]
2018-10-19 10-Q Quarterly report [Sections 13 or 15(d)] 2018-10-15 8-K Current report 2018-09-24